形态学与免疫组化分析鉴定成年Klinefelter综合征患者未分化精原细胞:队列研究
回顾性队列研究纳入79例成年Klinefelter综合征(KS)患者和12例对照,比较MAGE-A4与UCHL1(PGP9.5)免疫组化与苏木精-伊红(H&E)染色识别未分化精原细胞的效果。UCHL1和MAGE-A4阳性率分别为74.7%和40.5%,显著高于H&E的10.1%,对照者两种标志物均为100%阳性。作者认为UCHL1和MAGE-A4免疫染色似乎是识别KS患者睾丸活检中未分化精原细胞的有效方法。
要点
- UCHL1和MAGE-A4免疫染色识别KS患者未分化精原细胞的阳性率分别为74.7%和40.5%,H&E仅10.1%。
- KS患者UCHL1和MAGE-A4阳性小管平均数量分别为11.8±1.8和3.7±1.0。
- 睾丸取精阴性(n=72)的KS患者中,UCHL1和MAGE-A4阳性率分别为72.2%和34.7%,H&E为1.4%。
核心结论
- UCHL1和MAGE-A4免疫染色似乎是识别KS患者睾丸活检标本中未分化精原细胞的有效方法。
- 尽管观察到睾丸结构退化,许多KS患者仍存在未分化精原细胞,这些细胞可能被获取并潜在用于无精子症且睾丸取精阴性的KS患者的不育治疗。
研究设计与样本
- 回顾性队列研究,纳入79例成年KS患者和12例成年对照者。
- KS患者(n=79)接受双侧睾丸活检以尝试获取精子用于体外受精和卵胞浆内单精子注射;对照者(n=12)为通过National Disease Research Interchange同意成为器官捐献者的人员。
- 由泌尿生殖病理学家使用虚拟显微镜软件检查H&E、PGP9.5和MAGE-A4染色组织,判断未分化精原细胞和精子的存在。
主要发现
- KS组平均年龄32.9±0.7岁(范围16-48岁)。
- UCHL1(PGP9.5)和MAGE-A4染色显示KS患者中未分化精原细胞阳性率分别为74.7%(n=59)和40.5%(n=32),对照者两种标志物均为100%(n=12)阳性。
- H&E显微镜分析显示仅10.1%(n=8)的KS患者精原细胞阳性。
- KS患者UCHL1和MAGE-A4阳性小管平均数量分别为11.8±1.8和3.7±1.0。
- 二次分析显示7例(8.9%)成年KS患者活检精子阳性;睾丸取精阴性(n=72)的KS患者中,H&E、UCHL1和MAGE-A4的精原细胞阳性率分别为1.4%(n=1)、72.2%(n=52)和34.7%(n=25)。
临床怎么用
- 作者认为UCHL1和MAGE-A4免疫染色似乎是识别KS患者睾丸活检中未分化精原细胞的有效方法。
- 作者认为许多KS患者仍存在未分化精原细胞,这些细胞可能被获取并潜在用于无精子症且睾丸取精阴性的KS患者的不育治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the prevalence of spermatogonia in adult subjects with Klinefelter syndrome (KS) using MAGE-A4 and UCHL1 (PGP9.5) immunohistochemistry as markers for undifferentiated spermatogonial cells. We aimed to compare this method to the gold standard of hematoxylin and eosin (H & E) staining with histologic analysis in the largest reported cohort of adult subjects with KS. DESIGN: A retrospective cohort study. SETTING: Infertility Clinic and Institute for Regenerative Medicine. PATIENT(S): This study consisted of 79 adult subjects with KS and 12 adult control subjects. INTERVENTION(S): The subjects with KS (n = 79) underwent bilateral testicular biopsy in an initial effort to recover spermatozoa for in vitro fertilization and intracytoplasmic sperm injection. The institutional review board approved the use of a portion of the archived diagnostic pathology paraffin blocks for the study. The samples were superimposed onto microscopic slides and labeled with the PGP9.5 and MAGE-A4 antibodies. Subjects (n = 12) who had previously consented to be organ donors via the National Disease Research Interchange were selected as controls. Dedicated genitourinary pathologists examined the H & E-, PGP9.5-, and MAGE-A4-stained tissue for presence of undifferentiated spermatogonia and spermatozoa with the use of a virtual microscopy software. MAIN OUTCOME MEASURE(S): The primary outcome was the presence of MAGE-A4-positive or UCHL1-positive tubules that indicate undifferentiated spermatogonia. Supportive outcomes include assessing the biopsy specimen for the following: total surface area; total seminiferous tubule surface area; total interstitium surface area; the total number of seminiferous tubules; and MAGE-A4- negative or UCHL1-negative tubules. Additionally, clinical information, such as age, karyotype, height, weight, mean testicle size, and hormonal panel (luteinizing hormone, follicle-stimulating hormone, and testosterone), was obtained and used in a single and multivariable analysis with linear regression to determine predictive factors for the number of UCHL1-positive tubules. RESULT(S): The mean age of the subjects in the KS group was 32.9 ± 0.7 years (range, 16-48). UCHL1 (PGP9.5) and MAGE-A4 staining showed that 74.7% (n = 59) and 40.5% (n = 32) of the subjects with KS, respectively, were positive for undifferentiated spermatogonia compared with 100% (n = 12) of the control subjects who were positive for both the markers. Hematoxylin and eosin with microscopic analysis showed that only 10.1% (n = 8) of the subjects were positive for spermatogonia. The mean number of positive tubules per subject with KS was 11.8 ± 1.8 for UCHL1 and 3.7 ± 1.0 for MAGE-A4. Secondary analysis showed 7 (8.9%) adult subjects with KS as positive for spermatozoa on biopsy. The population having negative testicular sperm extraction results (n = 72) showed a spermatogonia-positive rate of 1.4%, (n = 1), 72.2% (n = 52), and 34.7% (n = 25) using H & E, UCHL1, and MAGE-A4, respectively. Further analysis showed that 54 (75.0%) subjects were either positive for UCHL1 or MAGE-A4. Twenty (27.8%) subjects were positive for both UCHL1 and MAGE-A4. Multivariate analysis with linear regression showed no significant correlation between clinical variables and the number of UCHL1-positive tubules found on biopsy specimens. CONCLUSION(S): We report a cohort of adult subjects with KS undergoing analysis for the presence of undifferentiated spermatogonia. UCHL1 and MAGE-A4 immunostaining appear to be an effective way of identifying undifferentiated spermatogonia in testicular biopsy specimens of subjects with KS. Despite observing deterioration in the testicular architecture, many patients remain positive for undifferentiated spermatogonia, which could be harvested and potentially used for infertility therapy in a patient with KS who is azoospermic and has negative testicular sperm extraction results.
引用
- Deebel NA, Soltanghoraee H, Bradshaw AW, et al. Morphometric and immunohistochemical analysis as a method to identify undifferentiated spermatogonial cells in adult subjects with Klinefelter syndrome: a cohort study. Fertil Steril. 2022. PMID: 36116982. doi:10.1016/j.fertnstert.2022.07.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。